Clinical Trial Update: Optimal Treatment of MRSA Throat Carriers [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating optimal treatment for MRSA throat carriers has completed. The study status is reported as COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methicillin-resistant Staphylococcus Aureus Infection

Snippet

Sponsor: Hvidovre University Hospital | Conditions: MRSA, MRSA Colonization | Phase 3 | Status: COMPLETED